ClinicalTrials.Veeva

Menu

Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens

T

Taipei Medical University

Status

Unknown

Conditions

Tuberculosis
Lung Cancer

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to study the Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens. Subjects are divided into two groups which are health group and Tuberculosis or lung cancer group in order to compare with the difference.

Enrollment

40 estimated patients

Sex

All

Ages

17 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Health group: between 17 to 90 years old
  • Tuberculosis group: people who are tuberculosis or lung cancer patients and between 17 to 90 years old

Exclusion criteria

  • Women subjects are before or after the period within two days

Trial design

40 participants in 2 patient groups

Health Group
Tuberculosis Group
Description:
Tuberculosis or lung cancer group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems